venBio Select Advisor »

Cerevel Therapeutics Hldng I shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2023-12-31 $320M 7.6M 42.40
2023-09-30 $21M 956k 21.83

More positions owned by venBio Select Advisor

Apellis Pharmaceuticals Common (APLS)
United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Argenx Se Sponsored ADR (ARGX)
Madrigal Pharmaceuticals Common (MDGL)
Sarepta Therapeutics Common (SRPT)
Biomarin Pharmaceutical Common (BMRN)
Spdr Series Trust - S&p Biotech Etf (XBI)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Krystal Biotech Common (KRYS)
Mirati Therapeutics Common
Cymabay Therapeutics Common
Xenon Pharmaceuticals Common (XENE)
Alnylam Pharmaceuticals Common (ALNY)

View all positions for venBio Select Advisor

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I